最新报道:Benchmark analysts initiated coverage on Semler Scientific (SMLR) with a "buy" rating and $101 price target, citing potential upside from its Bitcoin treasury strategy. The healthcare tech firm plans to accumulate 105,000 BTC by 2027 using financing proceeds and operational cash flows. Analyst Mark Palmer noted SMLR's mNAV of 1.25 lags behind peers like Metaplanet (4.29) and Blockchain Group (6.45), but expects improved valuation through execution and new initiatives like CardioVanta. The company has achieved 294% BTC Yield since launching its Bitcoin strategy in May 2024. SMLR shares rose 8.5% to $42.28 following the report.